Q4 2022 Torrent Pharmaceuticals Ltd Earnings Call Transcript

May 25, 2022 / 01:30PM GMT
Operator

Ladies and gentlemen, good day, and welcome to Q4 FY '22 Earnings Call of Torrent Pharmaceuticals Limited. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Sudhir Menon. Thank you, and over to you, sir.

Sudhir Menon - Torrent Pharmaceuticals Limited - Executive Director of Finance & CFO

Yes. Thank you, [Sara]. Good evening, and welcome, everyone, to Quarter 4 FY '22 Earnings Call. Quarter 4 witnessed strong growth in the branded generic market, aided by market share gains, performance of our top brands and new launches. The branded generic markets revenue constituted 70% of our total revenue in quarter 4, which grew by around 15%.

Our financial highlights for the quarter are as follows. Revenues were INR 2,131 crores, up by 10% on a Y-o-Y basis. The gross margins were at 71%, improved by 1% on a sequential basis. The EBITDA was INR 612 crores, up by 1% on a Y-o-Y basis. The operating EBITDA margins are at 26.3%.

This quarter, we have taken a difficult decision of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot